Figure 5: Conolidine is antinociceptive in visceral, tonic and persistent agony designs and is also present at micromolar concentrations while in the brain immediately after systemic injection. Conolidine CONOCB2™ in essence works by making a barrier in between the opioid receptors in the brain plus the "scavenger" receptors in https://hansb950pfv5.wikiap.com/user